TEK is a novel prognostic marker for clear cell renal cell carcinoma.
Ha M, Son YR, Kim J, Park SM, Hong CM, Choi D, Kang W, Kim JH, Lee KJ, Park D, Han ME, Oh SO, Lee D, Kim YH.
Ha M, et al.
Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1451-1458. doi: 10.26355/eurrev_201902_17102.
Eur Rev Med Pharmacol Sci. 2019.
PMID: 30840266
Free article.